Dopamine antagonist < Dopamine receptor < Dopaminergic neuron

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 70.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000351 (2011)	Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Steen Hvitfeldt Poulsen [Danemark]	The Risk of Valvular Regurgitation in Patients with Parkinson's Disease Treated with Dopamine Receptor Agonists
000644 (2011)	Morvarid Karimi [États-Unis] ; Stephen M. Moerlein [États-Unis] ; Tom O. Videen [États-Unis] ; Robert R. Luedtke [États-Unis] ; Michelle Taylor [États-Unis] ; Robert H. Mach [États-Unis] ; Joel S. Perlmutter [États-Unis]	Decreased Striatal Dopamine Receptor Binding in Primary Focal Dystonia: A D2 or D3 Defect?
000D27 (2009)	Susanne A. Schneider [Royaume-Uni] ; Vrajesh Udani [Inde] ; Charulata Sawant Sankhla [Inde] ; Kailash P. Bhatia [Royaume-Uni]	Recurrent Acute Dystonic Reaction and Oculogyric Crisis Despite Withdrawal of Dopamine Receptor Blocking Drugs
000F07 (2009)	Elena Garcia-Martin [Espagne] ; Carmen Martinez [Espagne] ; Hortensia Alonso-Navarro [Espagne] ; Julián Benito-Leon [Espagne] ; Inmaculada Puertas [Espagne] ; Lluisa Rubio [Espagne] ; Tomás Lopez-Alburquerque [Espagne] ; José A. G. Agundez [Espagne] ; Félix Javier Jimenez-Jimenez [Espagne]	Dopamine Receptor D3 (DRD3) Genotype and Allelic Variants and Risk for Essential Tremor
000F77 (2009)	Jee-Young Lee [Corée du Sud] ; EUN KYUNG LEE [Corée du Sud] ; SUNG SUP PARK [Corée du Sud] ; Ji-Yeon Lim [Corée du Sud] ; HEE JIN KIM [Corée du Sud] ; JI SUN KIM [Corée du Sud] ; Beom S. Jeon [Corée du Sud]	Association of DRD3 and GRIN2B with Impulse Control and Related Behaviors in Parkinson's Disease
001C13 (2006)	Kristian Winge [Danemark] ; Clare J. Fowler [Royaume-Uni]	Bladder dysfunction in parkinsonism : Mechanisms, prevalence, symptoms, and management
002039 (2004)	Jaume Campdelacreu [Espagne] ; Hatice Kumru [Espagne] ; Eduard Tolosa [Espagne] ; Josep Valls-Sole [Espagne] ; Antoni Benabarre [Espagne]	Progressive supranuclear palsy syndrome induced by clebopride
002171 (2004)	Ida Rissling [Allemagne] ; Frank Geller [Allemagne] ; Oliver Bandmann [Allemagne] ; Karim Stiasny-Kolster [Allemagne] ; Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; J. Carsten Möller [Allemagne]	Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks"
002316 (2003)	Sebastian Paus [Allemagne] ; Hans Michael Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Gert Seeger [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]	Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
002467 (2003)	Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France]	Efficacy of Piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study
002626 (2002)	Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Repeated administration of Piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: A behavioural and biochemical investigation
002666 (2002)	Giulio Cicarelli [Italie] ; Maria Teresa Pellecchia [Italie] ; Giuseppe De Michele [Italie] ; Gilberto Pizzolato [Italie] ; Paolo Barone [Italie]	Paradoxical response to apomorphine in a case of atypical parkinsonism
002672 (2002)	William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis]	Olanzapine treatment for dopaminergic-induced hallucinations
002708 (2002)	Petr Kanovsky [République tchèque] ; Dagmar Kubova [République tchèque] ; Martin Bares [République tchèque] ; Hana Hortova [République tchèque] ; Hana Streitova [République tchèque] ; Ivan Rektor [République tchèque] ; Vladimir Znojil [République tchèque]	Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up
002777 (2002)	Guillermo Paradiso [Canada] ; Farooq Khan [Canada] ; Robert Chen [Canada]	Effects of apomorphine on flexor reflex and periodic limb movement
002789 (2002)		Drugs to treat dementia and psychosis
002811 (2002)		DA agonists: Non-Ergot derivatives: Piribedil
002812 (2002)		DA agonists: Non-Ergot derivatives: Apomorphine
002813 (2002)		DA agonists: Ergot derivatives: Pergolide
002814 (2002)		DA agonists: Ergot derivatives: Lisuride
002815 (2002)		DA agonists: Ergot derivatives: Dihydroergocryptine (DHEC)

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "Dopamine receptor" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "Dopamine receptor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine receptor
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024